6% Dextran 70 / 7.5% NaCl
Medical Match’s Principal – Oresund Pharma ApS (Oresund Pharma) – is a Danish based specialty
pharmaceutical company focused on the commercialization and marketing of critical care niche
pharmaceutical products. Oresund Pharma’s geographical business focus is the Nordic region.
RescueFlow® - The Product
The point of use for RescueFlow® is in emergency settings which occur in for example ambulances, rescue helicopters and emergency rooms in hospitals. Since RescueFlow® was developed based on demand from various military forces, the Product is very suitable as standard equipment for the army all over the world. Several Military Forces order RescueFlow® and implement it into their medical aid procedures.
Oresund Pharma has global rights to RescueFlow®, and the Product is considered as being an attractive niche market opportunity with attractive profit margins.
This opportunity appeals to companies wishing to expand their emergency care product portfolio within specialty pharmaceuticals and/or hospital injectables. More specifically, the opportunity targets companies that have the marketing and commercial set-up to promote such a niche product for seriously injured patients in the prehospital emergency care setting – i.e. helicopters, ambulances and the military.
A potential acquirer has the option to continue the manufacturing of the Product at the existing EU based CMO or to move production to a new manufacturer, based on acquirer’s preferences.
RescueFlow® - Unique Selling Points
This business opportunity is offered as one global acquisition or on regional basis.
Medical Match has been retained by Oresund Pharma as their sole advisor in connection with finding acquirers for RescueFlow®.
All contacts in this matter should be directed to representatives of Medical Match.
Confidential Information will be released subject to execution of a Confidential Disclosure
For further information please contact: